Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study.
Igarashi T, Kobayashi Y, Ogura M, Kinoshita T, Ohtsu T, Sasaki Y, Morishima Y, Murate T, Kasai M, Uike N, Taniwaki M, Kano Y, Ohnishi K, Matsuno Y, Nakamura S, Mori S, Ohashi Y, Tobinai K; IDEC-C2B8 Study Group in Japan.
Igarashi T, et al. Among authors: murate t.
Ann Oncol. 2002 Jun;13(6):928-43. doi: 10.1093/annonc/mdf155.
Ann Oncol. 2002.
PMID: 12123339
Free article.
Clinical Trial.